Daniel Pryma
Chief of the Division of Nuclear Medicine & Clinical Molecular Imaging, Department of Radiology · University of Pennsylvania Health System
Credentials: · · ·
History
PresentDepartment of Radiology Division · University of Pennsylvania Health System
- Present
Nuclear Medicine and Clinical Molecular Imaging Division · University of Pennsylvania Health System
Research
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Nature · 2015 · 2,020 citations
The Lancet Oncology · 2007 · 268 citations
Journal of Nuclear Medicine · 2019 · First of 19 authors · Corresponding · 235 citations
24 papers
18 papers · 1 as a fellow
14 papers · 1 as a fellow
- HL
14 papers · 14 as a resident
8 papers
8 papers
- CD
7 papers
7 papers
Grants
- 2023–2028
National Cancer Institute · R01
Contact PI · $678.8K · University of Pennsylvania
- 2018–2024
PARP-1 as a Novel Target for Alpha-Particle Therapy in High-Risk Neuroblastoma
National Cancer Institute · R01
Contact PI · $3.1M · University of Pennsylvania
Clinical trials
- 2020–2027
Principal investigator · Recruiting · Phase 1
University of Pennsylvania
- 2016–2026
FDG PET/CT in Lung Cancer Staging
Principal investigator · Completed
Abramson Cancer Center at Penn Medicine
- 2014–2015
Circadian Brown Adipose Tissue Metabolism
Principal investigator · Completed
University of Pennsylvania
- 2009–2021
Principal investigator · Unknown · Phase 2
Molecular Insight Pharmaceuticals, Inc.